U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT07465562) titled 'Galactol(R) Enzyme Supplement for Post-Prandial Abdominal Bloating in Irritable Bowel Syndrome' on March 06.
Brief Summary: This multicenter, randomized, controlled clinical trial aims to evaluate the efficacy and safety of a dietary supplement containing a combination of digestive enzymes (alpha-galactosidase, beta-galactosidase, and prolyl-endopeptidase) in reducing post-prandial abdominal bloating in adults diagnosed with irritable bowel syndrome (IBS).
Participants will be randomly assigned in a 1:1 ratio to receive either the enzyme supplement (Galactol(R)) in addition to a diet excluding foods high in FODMAPs, or the diet al...